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suggesting a role for PLA2. Pretreatment with FB1 producedOxalate-induced ceramide accumulation in Madin-Darby ca-
a small but statistically insignificant attenuation of the responsenine kidney and LLC-PK1 cells.
to oxalate.Background. Oxalate exposure produces oxidant stress in
Conclusions. Oxalate exposure produces a marked accumu-renal epithelial cells leading to death of some cells and adapta-
lation of ceramide in renal epithelial cells by a process that istion of others. The pathways involved in these diverse actions
redox sensitive and mediated in part by activation of PLA2.remain unclear, but appear to involve activation of phospholi-
Since cellular sphingomyelin decreased as ceramide increased,pase A2 (PLA2) and redistribution of membrane phospholipids.
it seems likely that oxalate actions are mediated, at least inThe present studies examined the possibility that oxalate ac-
part, by an increase in sphingomyelinase activity, althoughtions may also involve increased accumulation of ceramide, a
alterations in ceramide synthase are also possible. Furtherlipid-signaling molecule implicated in a variety of pathways,
including those leading to apoptotic cell death. study is required to define the steps involved in oxalate actions
Methods. Ceramide accumulation was examined in renal ep- and to determine the extent to which ceramide signaling medi-
ithelial cells from pig kidney (LLC-PK1 cells) and from dog ates oxalate actions.
kidney [Madin-Darby canine kidney (MDCK cells)] using the
diacylglycerol kinase assay. Sphingomyelin degradation was
assessed by monitoring the disappearance of 3H-sphingomyelin
Studies in our own [1–6] and in other laboratoriesfrom cells that had been prelabeled with [3H]-choline. The
[7–11] have shown that exposure to high levels of oxalateeffects of oxalate were compared with those of other oxidants
(peroxide, xanthine/xanthine oxidase), other organic acids (for- produces oxidant stress in renal epithelial cells, causing
mate and citrate), and a known activator of sphingomyelinase frank toxicity in some cells and adaptation in others.
in these cells [tumor necrosis factor-a (TNF-a)]. Separate stud-
This finding has been of considerable interest to renalies determined whether oxalate-induced accumulation of cera-
pathologists in that cellular injury promotes the attach-mide could be blocked by pretreatment with antioxidants [Mn
(III) tetrakis (1-methyl-4-pyridyl) porphyrin (Mn TMPyP, a ment of crystals to renal epithelial cells [12–14]. Thus,
superoxide dismutase mimetic) or N-acetylcysteine (NAC; an high levels of oxalate in the urine could promote kidney
antioxidant)], with an inhibitor of ceramide synthase [fumoni- stone disease in several ways: by favoring the formation
sin B1 (FB1)] or with an inhibitor of PLA2 [arachidonyl triflu- of calcium oxalate crystals, by providing cellular debrisoromethylketone (AACOCF3)].
for crystal nucleation, and by promoting crystal adher-Results. Oxalate exposure produced a significant time- and
concentration-dependent increase in cellular ceramide. A re- ence to renal cells.
ciprocal decrease in 3H-sphingomyelin was observed under these Many or all of the cellular actions of oxalate appear
conditions. Increases in cellular ceramide levels were also ob- to be initiated by alterations in cellular membranes. Oxa-served after treatment with other oxidants (hydrogen peroxide,
late exposure increases membrane lipid peroxidationand xanthine/xanthine oxidase), activators of sphingomyelinase
[9–11], increases membrane permeability to vital dyes(TNF-a), exogenous sphingomyelinase, or arachidonic acid.
Formate produced similar (albeit smaller) effects, and citrate and to cytosolic enzymes [1–4, 7, 8], promotes a redistri-
did not. The oxidant-induced increases in ceramide were atten- bution of phosphatidylserine to the membrane surface
uated by pretreatment with NAC (a glutathione precursor)
(L.C. Cao, unpublished observations), and activates phos-and MnTMPyP (a superoxide dismutase mimetic), suggesting
pholipase A2 (PLA2) [15]. Any or all of these changesa role for cellular redox states. The oxalate-induced increase in
ceramide was also attenuated by pretreatment with AACOCF3, may contribute to the observed cytotoxicity of oxalate.
The possible linkage(s) between the observed membrane
alterations and cellular adaptation is less clear. OxalateKey words: renal epithelial cells, lipid signals, oxidant stress, PLA2,
apoptosis. treatment clearly induces a variety of adaptive responses
that range from an induction of immediate early genesReceived for publication July 2, 1999
(for example, c-myc, egr-1), initiation of DNA synthesisand in revised form November 23, 1999
Accepted for publication January 14, 2000 and cellular proliferation [1, 6], and an induction of genes
associated with remodeling and repair (for example, os-Ó 2000 by the International Society of Nephrology
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teopontin and clusterin; I. Jonassen, personal communi- nitrogen. The lipid extracts were stored at 2708C until
assayed for ceramide and sphingomyelin content.cation). However, studies to date (data not published)
Cellular ceramide was quantitated using the diacyl-have failed to detect an activation of signaling molecules
glycerol (DAG) kinase assay described previously [18](mitogen-activated protein kinase or JunK) that have
with minor modifications. In brief, the cell lipids werebeen implicated as mediators of other forms of oxidant
extracted from cultures as described previously in thisstress [16]. Given the evidence that oxalate affects cell
article and dried under nitrogen. The dried lipids weremembrane properties, it seemed likely that oxalate ac-
dissolved in 20 mL of 7.5% n-octyl-b-glucopyranoside,tions may be mediated by lipid-signaling molecules.
5 mmol/L cardiolipin, and 1 mmol/L diethylenetriamine-Thus, the present studies assessed the effects of oxalate
pentaacetic acid (DETAPAC, pH 7.0). The followingon the accumulation of ceramide, a lipid metabolite that
solutions were then added in order: 50 mL of reactionhas been implicated as an intracellular signal for a variety
buffer (100 mmol/L imidazole HCl, pH 6.6), 2 mL of 100of cellular responses, including cellular differentiation,
mmol/L dithiothreitol in 1 mmol/L DETAPAC, pH 7.0,proliferation, cytotoxicity, and cell death [17]. The results
10 mL of DAG kinase from E. coli (0.5 mg/mL in 100from our current studies provide evidence that oxalate
mmol/L imidazole HCl, pH 6.6, containing 1 mmol/Lexposure produces rapid and significant increases in cera-
DETAPAC; CalBiochem, La Jolla, CA, USA), and 8 mLmide that may mediate some of the observed effects of
of water. Note that these conditions provide an excessoxalate on renal cell growth and viability.
of added DAG kinase to insure quantitative conver-
sion of ceramide to ceramide 1-phosphate [reviewed in
METHODS 19]. The reaction was initiated by the addition of 10 mL
of 10 mmol/L cold adenosine 59-triphosphate (ATP) con-Cell culture
taining [g-32P] ATP (4.5 mCi for each sample; NENeMadin-Darby canine kidney (MDCK; CCL 34, passage
Life Science Products, Inc., Boston, MA, USA) in 2053 to 90) and LLC-PK1 cells (CRL 1392, passage 205 to
mmol/L imidazole, pH 6.6, 1 mmol/L DETAPAC and240) from the American Type Culture Collection (Rock-
was incubated at room temperature for 40 minutes. Theville, MD, USA) were plated on 100 or 60 mm dishes
reaction was stopped by the addition of 0.7 mL of 1%and maintained in Dulbecco’s modified Eagle’s medium
(wt/vol) perchloric acid, and the lipids were extracted(DMEM; GIBCO-BRL, Grand Island, NY, USA), sup-
with 5 mL of chloroform/methanol/1% perchloric acidplemented with 10% fetal bovine serum (FBS; Sigma,
(2:2:1, vol/vol/vol). The lower chloroform phase was
St. Louis, MO, USA), antibiotics 100 U/mL penicillin-
washed twice with 3 mL of 1% perchloric acid/methanol
100 mg/mL streptomycin (GIBCO-BRL), and 4.5 g/L (7:1, vol/vol). A portion of the chloroform phases (1.5
d-glucose. Cells were grown to approximately 80% con- and 0.1 mL, respectively) was aspirated and dried under
fluence at 378C under 5% CO2/95% air, washed twice nitrogen, with the former sample taken for ceramide
with serum-free DMEM, and incubated for predeter- determination and the latter taken for assay of lipid
mined periods in media containing the desired stimuli phosphorus. The 32P-labeled ceramide-1 phosphate was
or combinations of stimuli. The cells were then harvested separated from the rest of the lipids by thin layer chroma-
by scraping and were recovered by centrifugation. In tography (TLC) on silica gel 60 TLC plates (Merck,
some experiments, cells were dispersed further by tryp- Darmstadt, Germany) using chloroform/acetone/metha-
sinization, and assays were carried out in cell suspensions nol/acetic acid/water (50:20:15:10:5, vol/vol/vol/vol/vol)
containing equal numbers of cells in each tube (2 to 4 3 as the solvent. The plate was dried and subjected to
106 cells). In other cases, assays were performed using autoradiography overnight. The band of 32P-labeled cer-
the entire cell population from a given dish. Previous amide-1 phosphate was recovered by scraping and counted
studies have verified that cultures plated at the same time in a scintillation counter. The amount of ceramide in the
and grown under the same conditions show minimal vari- samples was compared with a standard curve generated
ability in cell density (,10% difference between dishes, by adding known amounts of ceramide (0 to 10 mg of
as assessed by cell counting or by determination of cell C2-ceramide) to the reaction mixture and processing
protein or lipid phosphorus; unpublished observations). these standards along with the experimental samples.
Data are expressed as a percentage of the ceramide in
Lipid extraction and ceramide assay untreated control cells. Estimates of the content of cera-
The harvested cells were recovered by centrifugation mide in controls are provided in the text.
(300 3 g, 10 min), washed twice with ice-cold phosphate-
Sphingomyelin assaybuffered saline (PBS), and extracted with 5 mL of chloro-
form:methanol:1% perchloric acid (2:2:1, vol/vol/vol). Sphingomyelin levels were measured as described by
The organic phase was washed twice with 2 mL of 1% Dressler, Mathias, and Kolesnick [20]. Two days before
the experiment, cells were transferred to DMEM me-perchloric acid:methanol (7:1, vol/vol) and dried under
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dium containing 10% FBS supplemented with 1 mCi/mL RESULTS
[methyl 3H]-choline chloride (NENe Life Science Prod- Oxalate-induced ceramide accumulation
ucts, Inc.). At the end of this period, the labeled medium Exposure of MDCK cells or LLC-PK1 cells to 0.5
was removed, and the cells [either in 60 mm dishes or mmol/L oxalate produced a time-dependent increase in
cell suspensions (1 to 2 3 106 cells per treatment group)] ceramide accumulation, with significant increases ob-
were incubated for an additional 30 minutes in fresh served within 15 minutes (Fig. 1A). Basal levels of cera-
DMEM supplemented with 10% FBS. The cultures were mide averaged 9.2 6 0.7 and 20.9 6 3.3 pmol/nmol lipid
then exposed to various agents for 0, 10, 20, 30, or 60 phosphorus in LLC-PK1 cells and MDCK cells, respec-
minutes. At the indicated times, the medium was rapidly tively, and the response to oxalate was greater in MDCK
removed. The cells were recovered (by scraping or by cells than in LLC-PK1 cells. The oxalate-induced accu-
centrifugation), washed with cold PBS, and sonicated in mulation of ceramide also exhibited concentration de-
400 mL of a chloroform/methanol/concentrated HCl solu- pendence in both cell lines, with significant increases
observed at 0.25 mmol/L oxalate (Fig. 1B). This concen-tion (100:100:1, vol/vol/vol) and 100 mL of PBS containing
tration of oxalate produces significant increases in free10 mmol/L ethylenediaminetetraacetic acid (EDTA).
radical production and modest (but statistically insig-After centrifugation for five minutes at 12,000 3 g, the
nificant) increases in membrane permeability to vitalaqueous phase was removed and re-extracted with 100
dyes in LLC-PK1 cells [3]. Other organic acids producedmL of chloroform, which was subsequently added to the
variable effects on ceramide production. In MDCK cells,chloroform phase. The combined chloroform phases
formate also produced a significant increase in ceramidewere dried under a stream of nitrogen. The extracted
accumulation, although the response to formate requireddried lipids were incubated in 50 mL of 0.1 mol/L metha-
a higher concentration (0.5 vs. 0.25 mmol/L) than thenolic potassium hydroxide for 60 minutes at 378C to
response to oxalate (Fig. 2). In LLC-PK1 cells, a similardeacylate glycerophospholipids. The samples then were
pattern was observed, although the response to formate
dried under nitrogen and redissolved in 40 mL of the
did not reach statistical significance in the limited series
chloroform phase. This solution was re-extracted with performed here (N 5 3). Formate shared the oxalate
10 mL of the PBS with 10 mmol/L EDTA and then re- transporter in the kidney [23], and produced modest
evaporated. The samples were then stored at 2708C increases in free radical production and in membrane
under nitrogen until they were analyzed for sphingomye- permeability in LLC-PK1 cells [3]. Citrate, a dicarboxy-
lin. The sphingomyelin was resolved by TLC using chlo- late that reportedly protects, afforded protection from
roform/methanol/acetic acid/water (60:30:8:5, vol/vol/ stone disease in vitro [24]; while it produced a modest
vol/vol) as solvent. Individual lipids were visualized with reduction in oxalate toxicity in LLC-PK1 cells [3], in our
iodine vapor staining and quantitated by liquid scintilla- study citrate did not increase ceramide accumulation in
tion counting. The results were expressed either as a either cell line (Fig. 2).
relative percentage as compared with controls or by lipid
Increases in ceramide correlate with decreasesphosphorus assay [21].
in sphingomyelin
Statistics Previous studies suggest that multiple pathways can
contribute to an increase in ceramide (for example, byTo assess the significance of the observed time- and
increased sphingolipid degradation, by reduced break-concentration-dependent changes in ceramide and sphin-
down of ceramide, or by increased synthesis of ceramide)gomyelin levels, data were analyzed using an analysis of
[17]. Thus, we carried out studies to distinguish amongvariance. Experimental treatments were considered to
these possibilities. The first series of studies examined
have produced statistically significant effects when the
the effects of oxalate on the breakdown of sphingomyelin
probability of chance occurrence was P , 0.05. To deter- in renal epithelial cells. Such studies revealed a signifi-
mine whether the antioxidants N-acetylcysteine (NAC) cant effect of oxalate on 3H-labeled sphingomyelin levels.
or MnTMPyP, the PLA2 inhibitor arachidonyl trifluoro- Exposure to 0.5 mmol/L oxalate produced a significant
methylketone (AACOCF3), or the ceramide synthase in- (40 to 50%) decline in cellular sphingomyelin within 30
hibitor fumonisin B1 (FB1) significantly attenuated re- minutes both in MDCK cells and in LLC-PK1 (Fig. 3).
sponses to oxalate or other oxidants, data were compared Similar effects could be observed after a two-hour expo-
with its respective control group (for example, oxalate sure to 50 ng/mL tumor necrosis factor-a (TNF-a; data
alone vs. oxalate plus other treatment) using a paired from two experiments not shown), a known activator
Student’s t-test. For comparing the effects of multiple of sphingomyelinase in many cells [25]. These studies
treatments with a single control, a Bonferroni correction suggest the involvement of sphingomyelinase in oxalate
actions, a possibility that is further supported by experi-was also applied [22].
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Fig. 2. Effect of other organic acids on ceramide accumulation in renal
epithelial cells. Suspensions of MDCK cells (A) and LLC-PK1 cells (B)
were prepared as described in the Methods section, and were exposed
to 0.25 or 0.5 mmol/L oxalate ( ), formate ( ), or citrate ( ) for one
hour (j, control). Lipids were extracted, and ceramide levels were
determined using the DAG assay. Note that oxalate exposure produced
a significant increase in ceramide levels at both 0.25 and 0.5 mmol/L
in both cell lines. Formate produced a significant increase in ceramide
only at 0.5 mmol/L and only in MDCK cells. Citrate produced no
significant effect at either concentration and in either cell line. Data
are mean 6 SEM (N 5 426 for MDCK cells and N 5 325 for LLC-Fig. 1. Time course (A) and concentration dependence (B) for oxalate-
PK1 cells). The asterisk denotes significance relative to untreated con-induced ceramide accumulation in MDCK (d) and in LLC-PK1 (h)
trols (*P , 0.05; **P , 0.01; ***P , 0.001).cells. (A) Cell suspensions were prepared as described in the text and
exposed to 0 or 0.5 mmol/L oxalate for the times indicated. Ceramide
levels were determined using the diacylglycerol kinase assay [18] and
data were expressed relative to levels in untreated controls. The time
course for oxalate-induced changes was similar in MDCK cells (d) and ments in which ceramide accumulation and sphingomye-
in LLC-PK1 cells (h), with significant increases seen within 15 minutes lin degradation were followed in the same batch of cellsin both cell types; however, the magnitude of the oxalate response was
on the same day. The latter studies showed that the increasegreater in MDCK cells (fourfold vs. twofold increase after 2 hours
exposure to 0.5 mmol/L oxalate). Data reflect mean 6 SEM from three in ceramide was paralleled by a decrease in 3H-labeled
independent experiments performed in duplicate (N 5 6). (B) Cells sphingomyelin in oxalate-treated MDCK and LLC-PK1were prepared as described in the text and exposed to oxalate (0, 250,
cells (Fig. 4), although the percentage changes in the500, or 1000 mmol/L) for 1 hour. Ceramide levels were determined and
expressed as a percentage of levels in untreated controls. After 1 hour two parameters were somewhat different.
of exposure, oxalate produced significant increases in ceramide in both Other studies examined the possibility that oxalateMDCK cells and LLC-PK1 cells at concentrations $ 250 mmol/L. Data
exposure may also stimulate ceramide synthesis in renalreflect the mean 6 SEM from three independent experiments per-
formed in duplicate (N 5 6) for each cell line. cells. LLC-PK1 cells and MDCK cells were pretreated
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Fig. 3. Oxalate-induced decline in 3H sphingomyelin levels in MDCK
(d) and LLC-PK1 (h) cells. Renal epithelial cells were labeled with
[3H]-choline for 48 hours and exposed to oxalate (0 or 0.5 mmol/L) for
0, 10, 20, 30, or 60 minutes. Lipids were extracted, chromatographed,
and visualized as described in the Methods section, and the amount of
3H sphingomyelin was then assessed. Data are means 6 SEM from
three independent experiments performed in duplicate (N 5 6) for
each cell line. Note that exposure to 0.5 mmol/L oxalate produced a
time-dependent decrease in 3H sphingomyelin levels in both MDCK
and LLC-PK1 cells, with significant declines seen by 10 minutes in both
cell lines. This effect was large, showing an approximately 40% decline
at 60 minutes, comparable to responses obtained with 50 mg/mL TNF-a
(data not shown).
Fig. 5. Pretreatment with fumonisin B1 (FB1), an inhibitor of ceramide
synthase, failed to attenuate oxalate actions on ceramide accumulation.
LLC-PK1 (B) and MDCK (A) cell suspensions were prepared as de-
scribed in the Methods section. Symbols are: (j), untreated controls;
(h) controls pretreated with FB1 (50 mmol/L) for 1 hour; ( ) oxalate
treated; ( ) pretreated with FB1 (50 mmol/L) for 1 hour prior to a
1-hour exposure to oxalate (0.25 or 0.5 mmol/L). Note that ceramide
accumulation was slightly reduced in fumonisin-treated cells, although
the effects were not statistically significant. FB1 treatment alone had
no significant effect on ceramide accumulation in two experiments. Data
are mean 6 SEM with N 5 6 for MDCK cells and N 5 3 for LLC-
PK1 cells.
with FB1 (an inhibitor of ceramide synthase) [26] and
were then exposed to 0.25 or 0.5 mmol/L oxalate for one
hour. Ceramide accumulation in cells treated with FB1 1
oxalate was compared with that in cells treated with
Fig. 4. Simultaneous measurement of oxalate actions on ceramide and oxalate alone. Such studies revealed only minimal effects
on sphingomyelin levels in renal cells. Large batches of MDCK (d) of FB1 treatment, however, in that the oxalate response
and LLC-PK1 cells (h) were prepared and used as described in Figures
of FB1-treated cells was similar to that in untreated cells1 and 2 such that oxalate’s actions on ceramide and on sphingomyelin
content could be examined in the same experiment. Data presented (FB1 did produce a small reduction in the oxalate re-
are means 6 SEM from three experiments with duplicate measurements sponse, but the effect was statistically insignificant and
in each experiment. Note the reciprocal relationship between the in-
was observed at the lower oxalate concentration; Fig. 5).crease in ceramide accumulation and the decrease in 3H sphingomyelin
content in both cell lines. These findings suggest that increased ceramide synthesis
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Table 1. Antioxidants attenuate oxidant-induced increases in
ceramide accumulation in renal epithelial cells
LLC-PK1 MDCK
Treatment % ceramide N % ceramide N
Ox 187.3614.0.6b 4 178.967.1b 7
Ox 1 NAC 110.3618.2a 3 113.3618.3a 3
Ox 1 MnTMPyP 128.4611.7a 5 128.664.56a 4
H2O2 205.3635.2b 4 254.2637.2b 6
H2O2 1 NAC 140.5625.2 3 150.7628.2 3
X/XO 213.6622.7b 4 305.1641.6b 5
X/XO 1 NAC 102.166.1a 4 137.0615.1a 3
LLC-PK1 and MDCK cells were exposed to oxidant (oxalate, 0.5 mmol/L for
1 hour; H2O2, 0.5 mmol/L for 0.5 hour or X/XO 1 mmol/L xanthine/50 mU
xanthine oxidase/mL for 1 hour) and assayed for ceramide as described in the
text. Where indicated cells were preincubated with antioxidants (NAC 10 mmol/L
or MnTMPyP 0.5 mmol/L) for 1 hour. Abbreviations are in the Appendix. Data
Fig. 6. N-acetylcysteine (NAC) attenuates oxalate-induced ceramideare expressed as a percentage of the ceramide levels in untreated controls.
accumulation in MDCK cells by decreasing sphingomyelin hydrolysis.Neither NAC or MnTMPyP alone had any effect.
MDCK cells were allowed to incorporate [3H]-choline for 48 hours anda P , 0.05 for oxidant 1 NAC (or MnTMPyP) vs. oxidant alone
were then washed and incubated for an additional hour in DMEM withb P , 0.05 for oxidant vs. untreated controls
(m) or without (d) 10 mmol/L NAC. The cells were then exposed to
0.5 mmol/L oxalate for varying times (0, 30, or 60 minutes) and processed
for sphingomyelin analysis (discussed in the Methods section). In these
studies, exposure to oxalate alone produced a marked decline in sphin-
may contribute to the oxalate-induced increases in cera- gomyelin with time. This decline was markedly attenuated by pretreat-
ment with NAC. Data are means from four wells from three separatemide accumulation, but other responses (for example,
platings.activation of SMase) likely play a greater role.
Oxalate-induced ceramide generation is
redox-sensitive and blocked by antioxidants
NAC for one hour blocked the oxalate-induced decrease
Oxalate-induced oxidative injury of renal epithelial in 3H-sphingomyelin.
cells has been demonstrated in our previous investiga-
tions [3], as well as in those of others [9–11]. Since recent Oxalate-induced ceramide generation is linked to the
PLA2 pathwayevidence showed that the sphingomyelin-ceramide path-
way is redox-sensitive in other cell types [25, 27], we Studies in other cell types have suggested that PLA2
examined the role of oxidant stress in oxalate-induced plays an important role in the processes leading to in-
ceramide generation. The responses to known oxidants creased ceramide accumulation and cell death [31]. Fur-
and to TNF-a, an agent that activates ceramide by a redox- thermore, our own studies suggested a role for PLA2 in
sensitive pathway [27, 28], were also examined. The ef- oxalate toxicity [15]. Thus, current studies assessed the
fects of two antioxidants—NAC, a known antioxidant possible role of PLA2 and/or its product, arachidonic
and efficient thiol source for glutathione [29], and acid (AA), in the oxalate-induced change in ceramide
MnTMPyP, a superoxide dismutase mimetic [30]—on accumulation. Such studies assessed the effect of exoge-
the response to oxalate were also evaluated. These stud- nous AA and mellitin (an activator of cPLA2) on cera-
ies showed that ceramide accumulation in renal epithelial mide generation in the renal epithelial cells and deter-
cells resembles the accumulation seen in other cell types mined whether AACOCF3, an inhibitor of PLA2, would
in that exposure to various oxidants [hydrogen peroxide block the oxalate response. In these studies, exposure
(500 mL), xanthine/xanthine oxidase (1 mmol/L xanthine to 25 mmol/L AA or 5 mg/mL mellitin caused a twofold
plus 50 mU/mL xanthine oxidase)] increases ceramide to sevenfold increase in ceramide, both in MDCK cells
levels. Moreover, preincubation of the cells with NAC and in LLC-PK1 cells (Table 2). Moreover, a 15-minute
(10 mmol/L for 1 h) significantly reduces the ceramide preincubation with 10 mmol/L AACOCF3 significantly
response. Similar effects were observed after pretreat- reduced ceramide accumulation in response to oxalate
ment of the cells with the superoxide dismutase (SOD) (Fig. 7). In preliminary studies, this pretreatment also
mimetic, MnTMPyP (0.5 mmol/L for 1 hour, tested only attenuated oxalate-induced changes in sphingomyelin
against oxalate). The data are summarized in Table 1. degradation (data not shown).
Other studies confirmed that the time-dependent in-
crease in ceramide was paralleled by a time-dependent
DISCUSSIONdecrease in 3H-labeled sphingomyelin by a redox-sensi-
tive process. As can be seen in Figure 6, treatment with This study presents the novel finding that oxalate ex-
posure directly alters sphingomyelin metabolism, re-oxalate led to a decline in 3H-labeled sphingomyelin lev-
els in the MDCK cells; pretreatment with 10 mmol/L sulting in a marked accumulation of ceramide in renal
Cao et al: Oxalate-induced ceramide generation 2409
Table 2. Agonist-induced accumulation of ceramide in renal droceramide (catalyzed by dihydroceramide desaturase)
epithelial cells
[17, 33]. More than one of these pathways may contribute
LLC-PK1 MDCK to oxalate actions in our cells. However, several lines of
Stimuli % ceramide N % ceramide N evidence suggest a major role for sphingomyelin degra-
dation in the oxalate-induced accumulation of ceramide.Arachidonic acid 200.3622.3a 5 234.6642.5a 11
Melittin 718.8 2 275.7630.4a 8 For one, oxalate exposure produced a fall in sphingomye-
TNF-a 229.5624.4a 7 232.0637.4a 10 lin levels coincident with the increase in ceramide accu-
Sphingomyelinase 298.6 2 527.5 2
mulation. Second, the addition of AA, a known activator
LLC-PK1 and MDCK cells were exposed to various agents, [arachidonic acid
of cytosolic Mg21-independent N-SMase [31], also in-(25 mmol/L for 60 minutes), melittin (2 mmol/L for 60 minutes), TNF-a (50
ng/mL for 30 minutes) or sphingomyelinase (200 mU/mL for 30 minutes)] and creased ceramide levels. Third, the addition of exogenous
assayed for ceramide as described in the text. Data are expressed as a percentage
N-SMase or TNF-a, a known activator of membraneof the ceramide levels in untreated controls.
a P , 0.05 for a given agent vs. untreated controls Mg21-dependent N-SMase [34], produced changes in cer-
amide that were comparable to those of oxalate, both
with respect to magnitude and time course. Fourth, pre-
treatment with FB1, an agent that reportedly inhibits cera-
mide synthase in renal cells [26], failed to block the oxa-
late-induced change in ceramide accumulation. Taken
together, these findings suggest that the oxalate-induced
change in ceramide is due, at least in part, to the activa-
tion of one or more sphingomyelinases in renal epithelial
cells, although other pathways may also play a role.
The type(s) of sphingomyelinase involved in oxalate
actions is as yet unclear. Studies in other cell types have
demonstrated that there are at least seven isoforms of
SMase that differ with respect to their pH optima (the
neutral or N-SMases are active at neutral pH, and the
Fig. 7. Role of phospholipase A2 (PLA2) in oxalate induced ceramide acidic or A-SMases are active at acidic pH), ionic depen-
generation. MDCK and LLC-PK1 cells were grown to approximately dence (some exhibit a Mg21 dependency, and others85% confluence in 60 mm cell culture dishes and were washed twice
do not) and intracellular location (some are membranewith serum-free DMEM. Cells were preincubated for 15 minutes in the
absence or presence of 10 mmol/L AACOCF3 (a selective blocker for bound, some are cytosolic, and others are confined to
PLA2), and then exposed to 0 or 0.5 mmol/L oxalate for one hour. Cells acidic organelles) [35]. Initial studies pointed to the mem-were then collected and lipid contents were analyzed as described in
brane N-SMase as the mediator of injury-dependent in-the text. Symbols are: (j) control; ( ) oxalate; ( ) oxalate 1 AA-
COCF3; ( ) AACOCF3. Ceramide levels are expressed as mean 6 creases in ceramide [20]. However, more recent studies
SEM from three independent experiments performed in duplicate for implicated both the N-SMase and the A-SMase in thiseach cell line (N 5 6). Note that the PLA2 inhibitor, AACOCF3 com-
response [17, 31]. Indeed, recent studies showed that stim-pletely blocked the oxalate-induced increase in ceramide in both cell
lines. Treatment with AACOCF3 alone had no effect on ceramide levels uli such as TNF-a activate both N-SMase and A-SMase
(N 5 2). *P , 0.05 relative to the untreated controls. via different pathways [one involving the c-Jun N-termi-
nal kinase/stress activated protein kinase (JNK/SAPK)
cascade of protein phosphorylations, and another involv-
ing TNF-a receptor activation of a cascade of cysteineepithelial cells. This finding is of significance given the
recent evidence indicating that ceramide triggers a num- proteases (caspases)] [reviewed in 35]. Thus, further
studies are required to determine the precise manner byber of signaling cascades that lead to diverse biological
responses ranging from differentiation and proliferation which oxalate activates SMase in renal cells and to iden-
tify the type(s) of SMase that might be involved.to apoptosis and necrosis [17, 32], and our own evidence
that oxalate triggers a similar range of responses in renal The results from the present studies and from those
reported previously suggest an involvement of PLA2 incells [1–6]. Thus, it is possible that ceramide accumula-
tion plays a central signaling role in oxalate actions on the generation of ceramide [17, 31]. Activation of PLA2
leads to increased ceramide formation in a number of cellrenal cells, including its effects on cellular viability.
Studies in other systems have demonstrated that sev- types, including kidney cells [31] and oxalate treatment
activates PLA2 in renal epithelial cells [15]. Moreover,eral processes can contribute to ceramide accumulation:
increased degradation of sphingomyelin (catalyzed by the present study showed that the addition of mellitin,
a known activator of PLA2, and AA, a product of PLA2acidic or neutral sphingomyelinases), decreased break-
down of ceramide (catalyzed by acidic or neutral cerami- activity, stimulated ceramide generation in MDCK and
LLC-PK1 cells. In addition, pretreatment with AACOCF3,dase), increased de novo synthesis of ceramide (catalyzed
by ceramide synthase), or increased degradation of dihy- a selective inhibitor of cytosolic PLA2, attenuated oxa-
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late-induced ceramide generation and sphingomyelin injury) that leads to an activation of PLA2. The activation
of this enzyme in turn generates byproducts [AA, thedegradation in renal epithelial cells. These findings suggest
that the PLA2/AA pathway is responsible, at least in part, precursor for a variety of active metabolites including
the prostaglandins, leukotrienes and epoxides, as well asfor the oxalate-induced ceramide generation, although
there is clearly “cross-talk” between the two lipid signal- lysolipids (which also have biological activity)] that may
activate sphingomyelinase(s) and generate ceramide.ing pathways. For example, other studies in our labora-
tory have shown that agents better known for their ef- The accumulation of ceramide may then initiate a series
of events, perhaps involving altered mitochondrial func-fects on ceramide generation (C2-ceramide, N-SMase,
and TNF-a) produce an apparent activation of PLA2 tion, that leads to cellular toxicity (perhaps via a caspase
cascade) or that lead to cellular adaptation/proliferationand a release of AA from MDCK cells (Y. Kohjimoto,
personal communication). Further study is thus required (perhaps via a stress kinase cascade) [reviewed in 17,
32, 35]. Further studies are required to assess the stepsto determine whether activation of the ceramide and
PLA2 pathways are causally linked or whether the two involved in oxalate actions and the role of ceramide in
these responses.pathways are both activated by some common action of
oxalate such as lipid peroxidation.
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exposure mimics the effects of other oxidants (peroxide,
Abbreviations used in this article are: AA, arachidonic acid;
xanthine/xanthine oxidase) with respect to ceramide ac- AACOCF3, arachidonyl trifluoromethylketone; DAG, diacylglycerol;
DETAPAC, diethylenetriamine-pentaacetic acid; DMEM, Dulbecco’scumulation in MDCK and in LLC-PK1 cells. Moreover,
modified Eagle’s medium; EDTA, ethylenediaminetetraacetic acid;these studies confirmed previous reports suggesting that
FB1, fumonisin B1; FBS, fetal bovine serum; GSH, glutathione sulfhy-
ceramide accumulation can be modulated by the avail- dryl; LLC-PK1, immortalized porcine cell line; MDCK, Madin-Darby
canine kidney; Mn TMPyP, Mn (III) tetrakis (l-methyl-4-pyridyl) por-ability of reduced glutathione sulfhydryl (GSH) [25, 36].
phyrin; NAC, N-acetylcysteine; PLA2, phospholipase A2; SOD, super-Preincubation of cells with NAC, an antioxidant that con-
oxide dismutase; TLC, thin layer chromatography; TNF-a, tumor ne-
fers protection by increasing cellular glutathione levels crosis factor-a.
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